Share Price and Basic Stock Data
Last Updated: February 11, 2026, 10:37 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Life Insurance Corporation of India (LIC) operates in the finance and life insurance sector, with a current market capitalization of ₹5,07,360 Cr. The company reported sales of ₹784,628 Cr for the year ending March 2023, which increased to ₹889,970 Cr by March 2025, indicating a consistent upward trend in revenue. Quarterly sales figures show a slight decline in the middle quarters of FY 2024, with ₹190,163 Cr in June 2023, followed by a recovery to ₹203,033 Cr in September 2023. The TTM revenue currently stands at ₹913,082 Cr, suggesting a strong performance relative to previous quarters. The operating profit margin (OPM) has shown improvement, rising to 6% by March 2025 from just 4% in March 2023, demonstrating enhanced operational efficiency. Overall, LIC’s revenue trajectory aligns well with industry growth, driven by an expanding insurance market and increasing demand for life insurance products in India.
Profitability and Efficiency Metrics
LIC’s profitability metrics display a robust performance, with a net profit of ₹51,098 Cr for the TTM, reflecting a significant increase from ₹35,997 Cr in March 2023. The company achieved a remarkable return on equity (ROE) of 45.7% and a return on capital employed (ROCE) of 53.1%, indicating effective utilization of shareholders’ funds and capital. The operating profit stood at ₹53,278 Cr for the financial year ending March 2025, with an OPM of 6%, up from 4% in the previous year. However, the company recorded fluctuations in quarterly operating profits, with a low of ₹1,564 Cr in March 2024, which improved to ₹21,514 Cr by March 2025. The interest coverage ratio (ICR) is exceptionally high at 387.69x, suggesting that LIC has ample earnings to cover its interest obligations, which is a significant strength in terms of financial stability. Nonetheless, the OPM remains lower than the industry average, indicating potential areas for operational improvement.
Balance Sheet Strength and Financial Ratios
LIC’s balance sheet reflects a solid financial position, with total assets amounting to ₹5,660,568 Cr as of March 2025. The company reported reserves of ₹135,608 Cr in September 2025, a substantial increase from ₹39,908 Cr in March 2023, indicating a strong accumulation of retained earnings. The debt levels are minimal, with borrowings recorded at just ₹1 Cr, showcasing a conservative approach to leveraging. The price-to-book value (P/BV) ratio stood at 3.98x, which is relatively high compared to typical sector averages, suggesting that the stock may be trading at a premium. The current ratio of 4.32x and quick ratio of 4.32x indicate excellent liquidity, allowing the company to meet short-term obligations comfortably. However, the high P/BV ratio could suggest overvaluation, which may pose a risk if market conditions change. Overall, LIC’s balance sheet is characterized by strong liquidity and minimal debt, placing it in a favorable position for future growth.
Shareholding Pattern and Investor Confidence
LIC’s shareholding structure reveals a dominant promoter presence, with promoters holding 96.50% of the total shares. This high concentration of ownership may contribute to stability in strategic decision-making but could deter foreign institutional investors (FIIs) and domestic institutional investors (DIIs) from increasing their stakes. FIIs hold a mere 0.20%, while DIIs have a slightly higher stake at 1.33%, indicating limited institutional interest in the stock. The total number of shareholders has declined from 33,78,799 in March 2023 to 21,55,417 in December 2025, reflecting potential concerns about liquidity or investor sentiment. Additionally, the public shareholding has decreased to 1.96%, which may suggest a lack of confidence among retail investors. This concentrated ownership could limit market participation and may affect the stock’s liquidity in the long term. Despite these factors, the strong promoter backing could be seen as a positive signal for long-term stability and growth.
Outlook, Risks, and Final Insight
Looking ahead, LIC’s growth potential remains significant, bolstered by rising insurance penetration in India and an expanding product portfolio. However, the company faces risks, including fluctuating operating profits and a high reliance on promoter support, which may limit broader market participation. The low levels of institutional investment could hinder stock performance if investor sentiment shifts negatively. Additionally, the relatively high P/BV ratio could signal overvaluation, posing a risk if market conditions change. In this context, LIC’s ability to improve its operational efficiency and diversify its shareholder base will be crucial for sustaining growth. Should the company successfully navigate these challenges and leverage its strong balance sheet and profitability metrics, it is positioned to capitalize on the growing demand for life insurance products in India. Conversely, failure to address these risks may impact investor confidence and stock performance in the future.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Life Insurance Corporation of India | 5,53,596 Cr. | 875 | 980/715 | 10.4 | 0.00 | 1.37 % | 53.1 % | 45.7 % | 10.0 |
| SBI Life Insurance Company Ltd (SBILIFE) | 2,03,239 Cr. | 2,026 | 2,116/1,380 | 82.0 | 190 | 0.13 % | 16.9 % | 15.1 % | 10.0 |
| Max Financial Services Ltd | 59,875 Cr. | 1,734 | 1,780/950 | 367 | 154 | 0.00 % | 8.13 % | 7.26 % | 2.00 |
| ICICI Prudential Life Insurance Company Ltd | 92,824 Cr. | 641 | 707/517 | 67.8 | 92.9 | 0.13 % | 11.9 % | 10.4 % | 10.0 |
| HDFC Life Insurance Company Ltd | 1,51,313 Cr. | 701 | 821/600 | 80.0 | 81.6 | 0.30 % | 6.58 % | 10.8 % | 10.0 |
| Industry Average | 212,169.40 Cr | 1,195.40 | 121.44 | 103.70 | 0.39% | 19.32% | 17.85% | 8.40 |
All Competitor Stocks of Life Insurance Corporation of India
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 217,092 | 197,714 | 201,231 | 190,163 | 203,033 | 214,054 | 238,717 | 211,952 | 231,132 | 203,751 | 243,134 | 224,671 | 241,524 |
| Expenses | 202,366 | 194,094 | 189,692 | 180,169 | 194,558 | 204,815 | 237,152 | 202,180 | 224,544 | 191,818 | 221,621 | 214,198 | 232,032 |
| Operating Profit | 14,727 | 3,620 | 11,539 | 9,994 | 8,475 | 9,239 | 1,564 | 9,773 | 6,588 | 11,934 | 21,514 | 10,474 | 9,492 |
| OPM % | 7% | 2% | 6% | 5% | 4% | 4% | 1% | 5% | 3% | 6% | 9% | 5% | 4% |
| Other Income | 6,046 | 270 | 612 | 117 | 288 | 206 | 14,249 | 1,001 | 794 | 818 | 954 | 780 | 1,044 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 20,772 | 3,891 | 12,151 | 10,111 | 8,763 | 9,445 | 15,813 | 10,774 | 7,382 | 12,752 | 22,468 | 11,253 | 10,537 |
| Tax % | 26% | -63% | 8% | 14% | 13% | 15% | 12% | 15% | 16% | 14% | 15% | 15% | 14% |
| Net Profit | 15,858 | 7,306 | 13,189 | 9,634 | 8,032 | 9,434 | 13,842 | 10,527 | 7,723 | 11,009 | 19,039 | 10,955 | 10,096 |
| EPS in Rs | 25.07 | 11.56 | 20.86 | 15.23 | 12.70 | 14.97 | 21.88 | 16.67 | 12.22 | 17.40 | 30.10 | 17.32 | 15.97 |
Last Updated: Unknown
Below is a detailed analysis of the quarterly data for Life Insurance Corporation of India based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 241,524.00 Cr.. The value appears strong and on an upward trend. It has increased from 224,671.00 Cr. (Jun 2025) to 241,524.00 Cr., marking an increase of 16,853.00 Cr..
- For Expenses, as of Sep 2025, the value is 232,032.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 214,198.00 Cr. (Jun 2025) to 232,032.00 Cr., marking an increase of 17,834.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 9,492.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10,474.00 Cr. (Jun 2025) to 9,492.00 Cr., marking a decrease of 982.00 Cr..
- For OPM %, as of Sep 2025, the value is 4.00%. The value appears to be declining and may need further review. It has decreased from 5.00% (Jun 2025) to 4.00%, marking a decrease of 1.00%.
- For Other Income, as of Sep 2025, the value is 1,044.00 Cr.. The value appears strong and on an upward trend. It has increased from 780.00 Cr. (Jun 2025) to 1,044.00 Cr., marking an increase of 264.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 10,537.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11,253.00 Cr. (Jun 2025) to 10,537.00 Cr., marking a decrease of 716.00 Cr..
- For Tax %, as of Sep 2025, the value is 14.00%. The value appears to be improving (decreasing) as expected. It has decreased from 15.00% (Jun 2025) to 14.00%, marking a decrease of 1.00%.
- For Net Profit, as of Sep 2025, the value is 10,096.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10,955.00 Cr. (Jun 2025) to 10,096.00 Cr., marking a decrease of 859.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 15.97. The value appears to be declining and may need further review. It has decreased from 17.32 (Jun 2025) to 15.97, marking a decrease of 1.35.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: Unknown
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 571,508 | 628,043 | 690,914 | 723,606 | 784,628 | 845,966 | 889,970 | 913,082 |
| Expenses | 565,587 | 634,989 | 691,166 | 720,280 | 750,498 | 813,316 | 836,692 | 859,668 |
| Operating Profit | 5,920 | -6,947 | -252 | 3,326 | 34,130 | 32,651 | 53,278 | 53,414 |
| OPM % | 1% | -1% | -0% | 0% | 4% | 4% | 6% | 6% |
| Other Income | 2,615 | 20,870 | 12,820 | 9,248 | 7,800 | 14,829 | 3,495 | 3,596 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 336 | 379 | 417 | 436 | 466 | 466 | 506 | 0 |
| Profit before tax | 8,199 | 13,544 | 12,151 | 12,138 | 41,463 | 47,014 | 56,267 | 57,009 |
| Tax % | 68% | 80% | 76% | 66% | 13% | 13% | 14% | |
| Net Profit | 2,627 | 2,710 | 2,974 | 4,125 | 35,997 | 40,916 | 48,320 | 51,098 |
| EPS in Rs | 6.52 | 56.91 | 64.69 | 76.40 | 80.79 | |||
| Dividend Payout % | 2% | 2% | 0% | 23% | 5% | 15% | 16% |
YoY Net Profit Growth
| Year | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 3.16% | 9.74% | 38.70% | 772.65% | 13.67% | 18.10% |
| Change in YoY Net Profit Growth (%) | 0.00% | 6.58% | 28.96% | 733.95% | -758.99% | 4.43% |
Life Insurance Corporation of India has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2019-2020 to 2024-2025.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: Unknown
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 100 | 100 | 100 | 6,325 | 6,325 | 6,325 | 6,325 | 6,325 |
| Reserves | 710 | 902 | 6,784 | 5,012 | 39,908 | 76,422 | 120,901 | 135,608 |
| Borrowings | 269,401 | 253,414 | 4 | 1 | 0 | 0 | 0 | 1 |
| Other Liabilities | 3,157,039 | 3,245,419 | 3,822,637 | 4,242,719 | 4,532,258 | 5,233,300 | 5,533,342 | 5,769,322 |
| Total Liabilities | 3,427,249 | 3,499,834 | 3,829,524 | 4,254,058 | 4,578,491 | 5,316,047 | 5,660,568 | 5,911,256 |
| Fixed Assets | 25,194 | 28,216 | 17,723 | 17,770 | 20,473 | 20,667 | 21,330 | 4,530 |
| CWIP | 710 | 734 | 148 | 199 | 331 | 403 | 326 | 0 |
| Investments | 2,900,287 | 2,976,100 | 3,517,445 | 3,926,211 | 4,243,008 | 4,976,133 | 5,298,429 | 5,571,626 |
| Other Assets | 501,059 | 494,784 | 294,208 | 309,878 | 314,678 | 318,844 | 340,483 | 335,099 |
| Total Assets | 3,427,249 | 3,499,834 | 3,829,524 | 4,254,058 | 4,578,491 | 5,316,047 | 5,660,568 | 5,911,256 |
Below is a detailed analysis of the balance sheet data for Life Insurance Corporation of India based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 6,325.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6,325.00 Cr..
- For Reserves, as of Sep 2025, the value is 135,608.00 Cr.. The value appears strong and on an upward trend. It has increased from 120,901.00 Cr. (Mar 2025) to 135,608.00 Cr., marking an increase of 14,707.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 5,769,322.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,533,342.00 Cr. (Mar 2025) to 5,769,322.00 Cr., marking an increase of 235,980.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 5,911,256.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,660,568.00 Cr. (Mar 2025) to 5,911,256.00 Cr., marking an increase of 250,688.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 4,530.00 Cr.. The value appears to be declining and may need further review. It has decreased from 21,330.00 Cr. (Mar 2025) to 4,530.00 Cr., marking a decrease of 16,800.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 326.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 326.00 Cr..
- For Investments, as of Sep 2025, the value is 5,571,626.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,298,429.00 Cr. (Mar 2025) to 5,571,626.00 Cr., marking an increase of 273,197.00 Cr..
- For Other Assets, as of Sep 2025, the value is 335,099.00 Cr.. The value appears to be declining and may need further review. It has decreased from 340,483.00 Cr. (Mar 2025) to 335,099.00 Cr., marking a decrease of 5,384.00 Cr..
- For Total Assets, as of Sep 2025, the value is 5,911,256.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,660,568.00 Cr. (Mar 2025) to 5,911,256.00 Cr., marking an increase of 250,688.00 Cr..
Notably, the Reserves (135,608.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | -264.00 | -259.00 | -256.00 | 2.00 | 34.00 | 32.00 | 53.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | |||||||
| Days Payable | |||||||
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | 78 | 63 | 35 | 42 | 43 | 39 | 38 |
| ROCE % | 5% | 9% | 131% | 143% | 73% | 53% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| ICICI Prudential Value Fund | 8,536,263 | 1.19 | 729.77 | N/A | N/A | N/A |
| ICICI Prudential Multi Asset Fund | 8,272,301 | 0.9 | 707.2 | N/A | N/A | N/A |
| Quant ELSS Tax Saver Fund | 6,867,735 | 4.73 | 587.12 | N/A | N/A | N/A |
| Kotak Multicap Fund | 3,539,880 | 1.31 | 302.62 | N/A | N/A | N/A |
| Quant Flexi Cap Fund | 3,231,253 | 4.12 | 276.24 | N/A | N/A | N/A |
| SBI Contra Fund | 3,101,220 | 0.53 | 265.12 | N/A | N/A | N/A |
| SBI Balanced Advantage Fund | 2,418,084 | 0.52 | 206.72 | N/A | N/A | N/A |
| SBI ELSS Tax Saver Fund | 2,347,834 | 0.62 | 200.72 | N/A | N/A | N/A |
| ICICI Prudential Large Cap Fund | 2,292,995 | 0.25 | 196.03 | N/A | N/A | N/A |
| ICICI Prudential Equity & Debt Fund | 2,278,421 | 0.39 | 194.78 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 76.40 | 64.69 | 56.91 | 6.52 | 4.70 |
| Diluted EPS (Rs.) | 76.40 | 64.69 | 56.91 | 6.52 | 4.70 |
| Cash EPS (Rs.) | 69.60 | 58.99 | 51.03 | 0.57 | 267.39 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 201.15 | 130.82 | 73.28 | 18.11 | 698.13 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 201.15 | 130.82 | 73.28 | 18.11 | 698.32 |
| Revenue From Operations / Share (Rs.) | 1407.07 | 1337.50 | 1240.52 | 1144.37 | 69094.19 |
| PBDIT / Share (Rs.) | 87.44 | 66.96 | 69.15 | 9.76 | 1358.35 |
| PBIT / Share (Rs.) | 86.64 | 66.22 | 68.41 | 9.07 | 1316.68 |
| PBT / Share (Rs.) | 86.41 | 66.02 | 68.29 | 8.93 | 1305.32 |
| Net Profit / Share (Rs.) | 68.80 | 58.25 | 50.30 | -0.11 | 225.73 |
| NP After MI And SOA / Share (Rs.) | 76.39 | 64.69 | 56.91 | 6.52 | 297.41 |
| PBDIT Margin (%) | 6.21 | 5.00 | 5.57 | 0.85 | 1.96 |
| PBIT Margin (%) | 6.15 | 4.95 | 5.51 | 0.79 | 1.90 |
| PBT Margin (%) | 6.14 | 4.93 | 5.50 | 0.78 | 1.88 |
| Net Profit Margin (%) | 4.88 | 4.35 | 4.05 | 0.00 | 0.32 |
| NP After MI And SOA Margin (%) | 5.42 | 4.83 | 4.58 | 0.56 | 0.43 |
| Return on Networth / Equity (%) | 37.98 | 49.44 | 77.86 | 36.38 | 43.21 |
| Return on Capital Employeed (%) | 0.97 | 0.79 | 0.95 | 0.13 | 0.35 |
| Return On Assets (%) | 0.85 | 0.76 | 0.78 | 0.09 | 0.07 |
| Asset Turnover Ratio (%) | 0.16 | 0.17 | 0.17 | 0.17 | 0.18 |
| Current Ratio (X) | 4.32 | 3.09 | 3.32 | 2.78 | 2.23 |
| Quick Ratio (X) | 4.32 | 3.09 | 3.32 | 2.78 | 2.23 |
| Dividend Payout Ratio (NP) (%) | 7.85 | 10.82 | 2.63 | 0.67 | 0.42 |
| Dividend Payout Ratio (CP) (%) | 7.77 | 10.69 | 2.60 | 0.60 | 0.37 |
| Earning Retention Ratio (%) | 92.15 | 89.18 | 97.37 | 99.33 | 99.58 |
| Cash Earning Retention Ratio (%) | 92.23 | 89.31 | 97.40 | 99.40 | 99.63 |
| Interest Coverage Ratio (X) | 387.69 | 331.18 | 564.85 | 71.21 | 119.55 |
| Interest Coverage Ratio (Post Tax) (X) | 328.43 | 279.85 | 488.24 | -26.24 | 35.12 |
| Enterprise Value (Cr.) | 436329.36 | 536812.76 | 292784.51 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 0.49 | 0.63 | 0.37 | 0.00 | 0.00 |
| EV / EBITDA (X) | 7.89 | 12.68 | 6.69 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 0.56 | 0.68 | 0.43 | 0.00 | 0.00 |
| Retention Ratios (%) | 92.14 | 89.17 | 97.36 | 99.32 | 99.57 |
| Price / BV (X) | 3.98 | 6.99 | 7.31 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 0.56 | 0.68 | 0.43 | 0.00 | 0.00 |
| EarningsYield | 0.09 | 0.07 | 0.10 | 0.00 | 0.00 |
After reviewing the key financial ratios for Life Insurance Corporation of India, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 76.40. This value is within the healthy range. It has increased from 64.69 (Mar 24) to 76.40, marking an increase of 11.71.
- For Diluted EPS (Rs.), as of Mar 25, the value is 76.40. This value is within the healthy range. It has increased from 64.69 (Mar 24) to 76.40, marking an increase of 11.71.
- For Cash EPS (Rs.), as of Mar 25, the value is 69.60. This value is within the healthy range. It has increased from 58.99 (Mar 24) to 69.60, marking an increase of 10.61.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 201.15. It has increased from 130.82 (Mar 24) to 201.15, marking an increase of 70.33.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 201.15. It has increased from 130.82 (Mar 24) to 201.15, marking an increase of 70.33.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,407.07. It has increased from 1,337.50 (Mar 24) to 1,407.07, marking an increase of 69.57.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 87.44. This value is within the healthy range. It has increased from 66.96 (Mar 24) to 87.44, marking an increase of 20.48.
- For PBIT / Share (Rs.), as of Mar 25, the value is 86.64. This value is within the healthy range. It has increased from 66.22 (Mar 24) to 86.64, marking an increase of 20.42.
- For PBT / Share (Rs.), as of Mar 25, the value is 86.41. This value is within the healthy range. It has increased from 66.02 (Mar 24) to 86.41, marking an increase of 20.39.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 68.80. This value is within the healthy range. It has increased from 58.25 (Mar 24) to 68.80, marking an increase of 10.55.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 76.39. This value is within the healthy range. It has increased from 64.69 (Mar 24) to 76.39, marking an increase of 11.70.
- For PBDIT Margin (%), as of Mar 25, the value is 6.21. This value is below the healthy minimum of 10. It has increased from 5.00 (Mar 24) to 6.21, marking an increase of 1.21.
- For PBIT Margin (%), as of Mar 25, the value is 6.15. This value is below the healthy minimum of 10. It has increased from 4.95 (Mar 24) to 6.15, marking an increase of 1.20.
- For PBT Margin (%), as of Mar 25, the value is 6.14. This value is below the healthy minimum of 10. It has increased from 4.93 (Mar 24) to 6.14, marking an increase of 1.21.
- For Net Profit Margin (%), as of Mar 25, the value is 4.88. This value is below the healthy minimum of 5. It has increased from 4.35 (Mar 24) to 4.88, marking an increase of 0.53.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.42. This value is below the healthy minimum of 8. It has increased from 4.83 (Mar 24) to 5.42, marking an increase of 0.59.
- For Return on Networth / Equity (%), as of Mar 25, the value is 37.98. This value is within the healthy range. It has decreased from 49.44 (Mar 24) to 37.98, marking a decrease of 11.46.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.97. This value is below the healthy minimum of 10. It has increased from 0.79 (Mar 24) to 0.97, marking an increase of 0.18.
- For Return On Assets (%), as of Mar 25, the value is 0.85. This value is below the healthy minimum of 5. It has increased from 0.76 (Mar 24) to 0.85, marking an increase of 0.09.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.16. It has decreased from 0.17 (Mar 24) to 0.16, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 4.32. This value exceeds the healthy maximum of 3. It has increased from 3.09 (Mar 24) to 4.32, marking an increase of 1.23.
- For Quick Ratio (X), as of Mar 25, the value is 4.32. This value exceeds the healthy maximum of 2. It has increased from 3.09 (Mar 24) to 4.32, marking an increase of 1.23.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 7.85. This value is below the healthy minimum of 20. It has decreased from 10.82 (Mar 24) to 7.85, marking a decrease of 2.97.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 7.77. This value is below the healthy minimum of 20. It has decreased from 10.69 (Mar 24) to 7.77, marking a decrease of 2.92.
- For Earning Retention Ratio (%), as of Mar 25, the value is 92.15. This value exceeds the healthy maximum of 70. It has increased from 89.18 (Mar 24) to 92.15, marking an increase of 2.97.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 92.23. This value exceeds the healthy maximum of 70. It has increased from 89.31 (Mar 24) to 92.23, marking an increase of 2.92.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 387.69. This value is within the healthy range. It has increased from 331.18 (Mar 24) to 387.69, marking an increase of 56.51.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 328.43. This value is within the healthy range. It has increased from 279.85 (Mar 24) to 328.43, marking an increase of 48.58.
- For Enterprise Value (Cr.), as of Mar 25, the value is 436,329.36. It has decreased from 536,812.76 (Mar 24) to 436,329.36, marking a decrease of 100,483.40.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 1. It has decreased from 0.63 (Mar 24) to 0.49, marking a decrease of 0.14.
- For EV / EBITDA (X), as of Mar 25, the value is 7.89. This value is within the healthy range. It has decreased from 12.68 (Mar 24) to 7.89, marking a decrease of 4.79.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 1. It has decreased from 0.68 (Mar 24) to 0.56, marking a decrease of 0.12.
- For Retention Ratios (%), as of Mar 25, the value is 92.14. This value exceeds the healthy maximum of 70. It has increased from 89.17 (Mar 24) to 92.14, marking an increase of 2.97.
- For Price / BV (X), as of Mar 25, the value is 3.98. This value exceeds the healthy maximum of 3. It has decreased from 6.99 (Mar 24) to 3.98, marking a decrease of 3.01.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 1. It has decreased from 0.68 (Mar 24) to 0.56, marking a decrease of 0.12.
- For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.07 (Mar 24) to 0.09, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Life Insurance Corporation of India:
- Net Profit Margin: 4.88%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.97% (Industry Average ROCE: 19.32%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 37.98% (Industry Average ROE: 17.85%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 328.43
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.32
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 10.4 (Industry average Stock P/E: 121.44)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.88%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance - Life Insurance | Yogakshema, Mumbai Maharashtra 400021 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Doraiswamy Ramchandran | Managing Director & CEO |
| Mr. Dinesh Pant | Managing Director |
| Mr. Ratnakar Patnaik | Managing Director |
| Mr. Sat Pal Bhanoo | Managing Director |
| Dr. Ranjan Sharma | Independent Director |
| Prof. Anil Kumar | Independent Director |
| Mr. Vinod Kumar Verma | Independent Director |
| Mrs. Anjuly Chib Duggal | Independent Director |
| Mr. G Mahalingam | Independent Director |
| Mr. Raj Kamal | Independent Director |
| Dr. V S Parthasarthy | Independent Director |
| Mr. Muthu Raju Paravasa Raju Vijay Kumar | Independent Director |
| Dr. Parshant Kumar Goyal | Government Nominee Director |
FAQ
What is the intrinsic value of Life Insurance Corporation of India?
Life Insurance Corporation of India's intrinsic value (as of 11 February 2026) is ₹1365.50 which is 56.06% higher the current market price of ₹875.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹5,53,596 Cr. market cap, FY2025-2026 high/low of ₹980/715, reserves of ₹135,608 Cr, and liabilities of ₹5,911,256 Cr.
What is the Market Cap of Life Insurance Corporation of India?
The Market Cap of Life Insurance Corporation of India is 5,53,596 Cr..
What is the current Stock Price of Life Insurance Corporation of India as on 11 February 2026?
The current stock price of Life Insurance Corporation of India as on 11 February 2026 is ₹875.
What is the High / Low of Life Insurance Corporation of India stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Life Insurance Corporation of India stocks is ₹980/715.
What is the Stock P/E of Life Insurance Corporation of India?
The Stock P/E of Life Insurance Corporation of India is 10.4.
What is the Book Value of Life Insurance Corporation of India?
The Book Value of Life Insurance Corporation of India is 0.00.
What is the Dividend Yield of Life Insurance Corporation of India?
The Dividend Yield of Life Insurance Corporation of India is 1.37 %.
What is the ROCE of Life Insurance Corporation of India?
The ROCE of Life Insurance Corporation of India is 53.1 %.
What is the ROE of Life Insurance Corporation of India?
The ROE of Life Insurance Corporation of India is 45.7 %.
What is the Face Value of Life Insurance Corporation of India?
The Face Value of Life Insurance Corporation of India is 10.0.
